Eyegene Inc.

This study tests a new vaccine designed to protect against four types of meningococcal bacteria that cause serious infections like meningitis and sepsis. About 1,100 healthy adults aged 19 to 55 will receive a single dose to see how well it triggers the immune system and if it is…